Some strong news flow coming out of this UK biotech - driving a doubling in share price in < 1 week!

They are the sole contract manufacturer for a potential Novartis blockbuster currently under-review by the FDA http://www.stockopedia.com/share-prices/oxford-biomedica-LON:OXB/news/rns/170614oxb1002i.htm/?title=findings-from-phase-ii-juliet-study

And they have now refinanced on more favourable terms.

http://www.stockopedia.com/share-prices/oxford-biomedica-LON:OXB/news/rns/170630oxb7350j.htm/?title=refinancing-of-debt-facility

Disclosure, I am long.

Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here